Newamsterdam Pharma CO N.V. (NAMSW) SEC Filings — 2025

Filings

• NewAmsterdam Pharma's Q3 Loss Widens on Warrant Valuation Swings — 10-Q · Nov 5, 2025
• NewAmsterdam Pharma Files 8-K — 8-K · Sep 2, 2025
• NewAmsterdam Pharma Files 8-K — 8-K · Aug 18, 2025
• NewAmsterdam Pharma Enters Material Definitive Agreement — 8-K · Aug 15, 2025
• NewAmsterdam Pharma's Q2 Loss Widens Amid R&D Surge — 10-Q · Aug 6, 2025
• NewAmsterdam Pharma Files 8-K on July 30, 2025 — 8-K · Jul 30, 2025
• NewAmsterdam Pharma Files 8-K on Officer/Director Changes — 8-K · Jul 11, 2025
• Newamsterdam Pharma CO N.V. 8-K Filing — 8-K · Jun 11, 2025
• NewAmsterdam Pharma Files 8-K — 8-K · Jun 9, 2025
• NewAmsterdam Pharma Files 8-K on Shareholder Votes & Financials — 8-K · Jun 6, 2025
• NewAmsterdam Pharma Executive Compensation Details Released — DEF 14A · May 8, 2025
• NewAmsterdam Pharma Q1 2025 10-Q Filed — 10-Q · May 8, 2025
• NewAmsterdam Pharma Files 8-K — 8-K · May 7, 2025
• NewAmsterdam Pharma Reports Director/Officer Changes — 8-K · Apr 17, 2025
• NewAmsterdam Pharma Files 8-K on Financials — 8-K · Feb 26, 2025
• NewAmsterdam Pharma Files 8-K — 8-K · Jan 10, 2025